ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Market Cap	$1.94B	P/E Ratio	13.70
52W High	$99.50	52W Low	$52.50
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	32.6%	52W Position	59.1%
Overall Score	52	Value Score	55
Quality Score	--	Technical Score	50

EPS Current Est	$5.86	EPS Next Est	$6.31
EPS Growth Est	+7.7%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ANIP	$80.30	+2.27%	165.37K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ANIP	$80.30	+2.3%	165.37K
3
4
5
6

ANIP

ANIP

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get ANI Pharmaceuticals Inc. Data in Excel

Get ANI Pharmaceuticals Inc. Data in Excel